Banner

Steroids, laser provide options for treating retinal edema

Article

Debate weighs merits of both modalities; further research may elucidate preferences

Related Videos
Related Content

Digital healthcare startup eyecbetter kicks off Regulation C crowdfunding campaign on StartEngine

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 27th 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Digital healthcare startup eyecbetter kicks off Regulation C crowdfunding campaign on StartEngine

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 27th 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Digital healthcare startup eyecbetter kicks off Regulation C crowdfunding campaign on StartEngine

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 27th 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023
© 2023 MJH Life Sciences

All rights reserved.